Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Feb;42(2):98-102.
doi: 10.1136/jmg.2004.024802.

Milroy disease and the VEGFR-3 mutation phenotype

Affiliations
Review

Milroy disease and the VEGFR-3 mutation phenotype

G Brice et al. J Med Genet. 2005 Feb.

Abstract

Primary congenital lymphoedema (Milroy disease) is a rare autosomal dominant condition for which a major causative gene defect has recently been determined. Mutations in the vascular endothelial growth factor receptor 3 (VEGFR-3) gene have now been described in 13 families world-wide. This is a review of the condition based on the clinical findings in 71 subjects from 10 families. All 71 individuals have a mutation in VEGFR-3. Ninety per cent of the 71 individuals carrying a VEGFR-3 mutation showed signs of oedema, which was confined in all cases to the lower limbs. In all but two cases onset of swelling was from birth. Other symptoms and signs included cellulitis (20%), large calibre leg veins (23%), papillomatosis (10%), and upslanting toenails (10%). In males, hydrocoele was the next most common finding after oedema (37%). Thorough clinical examination of these patients indicates that there are few clinical signs in addition to lower limb oedema. Rigorous phenotyping of patients produces a high yield of VEGFR-3 mutations.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Nat Genet. 2000 Jun;25(2):153-9 - PubMed
    1. Am J Hum Genet. 1999 Feb;64(2):547-55 - PubMed
    1. Am J Hum Genet. 2000 Dec;67(6):1382-8 - PubMed
    1. Am J Med Genet. 2001 Feb 1;98(4):303-12 - PubMed
    1. Nat Med. 2001 Feb;7(2):199-205 - PubMed

Publication types

Substances